Search | UNICEF

Доступно на:
English
русский
Українська

11 Февраль 2021

UNICEF signs supply agreement for Pfizer/BioNTech COVID-19 vaccine

https://www.unicef.org/eca/press-releases/unicef-signs-supply-agreement-pfizerbiontech-covid-19-vaccine

NEW YORK, 11 February 2021: UNICEF announced today the signing of an agreement with Pfizer on behalf of the COVAX Facility for the supply of the Pfizer-BioNTech COVID-19 Vaccine through 2021. Deliveries of the vaccine are anticipated to start as early as the first quarter of 2021, once the countries that were allocated Pfizer-BioNTech vaccine…

10 Февраль 2021

In the COVID-19 vaccine race, we either win together or lose together

https://www.unicef.org/eca/press-releases/covid-19-vaccine-race-we-either-win-together-or-lose-together

NEW YORK/GENEVA, 10 February 2021 – “Of the 128 million vaccine doses administered so far, more than three quarters of those vaccinations are in just 10 countries that account for 60 per cent of global GDP. “As of today, almost 130 countries, with 2.5 billion people, are yet to administer a single dose. “This self-defeating strategy will cost…

15 Декабрь 2020

Teachers should be prioritized for vaccination against COVID-19

https://www.unicef.org/eca/press-releases/teachers-should-be-prioritized-vaccination-against-covid-19

NEW YORK, 15 December 2020 – “The COVID-19 pandemic has wreaked havoc on children’s education around the globe. Vaccinating teachers is a critical step towards putting it back on track. “At their peak in late April 2020, nationwide school closures disrupted the learning of almost 90 per cent of students worldwide. While that number has dropped…

16 Июнь 2021

UNICEF signs supply agreement for Sputnik V COVID-19 vaccine

https://www.unicef.org/eca/press-releases/unicef-signs-supply-agreement-sputnik-v-covid-19-vaccine

NEW YORK/COPENHAGEN, 27 May 2021 - UNICEF and Human Vaccine (Limited Liability Company), a wholly-owned subsidiary of the Russian Direct Investment Fund (RDIF), today announced a long-term agreement (LTA) for the supply of the Sputnik V COVID-19 vaccine. This is the fourth long-term supply agreement UNICEF has signed with a COVID-19 vaccine manufacturer. So far this year, UNICEF has signed such agreements with the Serum Institute of India, Pfizer and AstraZeneca. Procurement by UNICEF under this agreement is conditional on the product achieving an Emergency Use Listing from WHO, to confirm the quality, safety and efficacy of the vaccine. In addition, an Advance Purchase Agreement (APA) with Gavi, the Vaccine Alliance, will also be needed for procurement to begin on behalf of the COVAX Facility. Should the COVAX Facility decide to enter into an advance purchase agreement for the supply of the Sputnik V vaccine, UNICEF will be ready to deliver as soon as regulatory milestones have been met. At this point, UNICEF through this LTA, stands ready to access up to 220 million doses of the vaccine available for supply in 2021, to meet country demand. The Sputnik V vaccine consists of two different components of the vaccine to be administered 21 days apart. An exact delivery schedule will be determined in collaboration with the manufacturer. UNICEF’s priority is to make sure that all countries have safe, fast and equitable access to COVID-19 vaccine and to help them prepare for the rollout of immunization. The best way to bring the pandemic under control is to ensure that safe and effective vaccines are made available as widely as possible and as quickly as possible, reducing inequity by ensuring that no country or territory is left behind due to its economic status. On 24 February 2021, COVID-19 vaccine vials are produced for the COVAX facility at a manufacturer in Pune, a city located in the western Indian state of Maharashtra. UNICEF/UN0421679?Singh

14 Февраль 2018

Tackling sexual exploitation and abuse of children: Actions and commitments

https://www.unicef.org/eca/press-releases/tackling-sexual-exploitation-and-abuse-children-actions-and-commitments

STOCKHOLM, 14 February 2018 – “Sexual exploitation and abuse of children under any circumstances is reprehensible. No organization is immune from this scourge and we are continuously working to better address it. When it comes to the protection of children, we are determined to act. There is no room for complacency. “As UNICEF’s Executive Director, I have put this issue at the top of our agenda and we are committed to strong action and transparency within UNICEF. “To make sure we are doing everything possible, we are commissioning an independent review of our procedures and I will make its recommendations public. “My team is also exploring ways to use technology to quickly assess the risks of sexual exploitation of abuse, and facilitate safe and confidential reporting by the victims. “Starting in locations where the risk of sexual exploitation and abuse is higher, we are implementing more stringent vetting of all personnel and improving safety and protection around children in our operations. “These new measures add to the strong and determined actions we have taken over the years to prevent the abuse of children and respond to the needs of those affected, building on the lessons we have learned and a regular assessment of our approaches: We have made the reporting of sexual exploitation and abuse mandatory, through a notification alert that reports information to me within 24 hours. We have scaled up our assistance to victims and are providing them with safe and confidential support; We are rolling-out community-based complaint mechanisms; We have strengthened our investigations unit; and We have made training on the prevention of sexual exploitation and abuse mandatory. “We have zero tolerance for sexual exploitation and abuse, and we remain committed to continually learning and improving. We want justice for the child victims and are determined to work with all partners to achieve it.” Statement by UNICEF Executive Director Henrietta H. Fore.